Skip to main content
. 2022 Feb 9;9:832954. doi: 10.3389/fmed.2022.832954

Table 4.

The incidence of DES, FES and MGD in patients.

Group A (n = 21) Group B (n = 20) Group C (n = 62)
DES (n, %) 4 (19.1%) 6(30%) 27 (43.6%)*
LDDE/ATD 4/0 6/0 27/0
FES (n, %) 0 0 12 (19.4%)*
MGD (n, %) 7 (33.3%) 9 (45%) 40 (64.5%)*

DES, dry eye syndrome; LDDE, lipid-deficient dry eye; ATD, aqueous tear deficiency; FES, floppy eyelid syndrome; MGD, meibomian gland dysfunction. Compared with Group A:

*

P < 0.05, Chi-square test.